4.4 Article

Influence of the coating formulation on enzymatic digestibility and drug release from 5-aminosalicylic acid pellets coated with mixtures of high-amylose starch and Surelease (R) intended for colon-specific drug delivery

期刊

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
卷 36, 期 2, 页码 161-172

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/03639040903124617

关键词

alpha-Amylases; colon-specific delivery; film coating; high-amylose starch; in vitro drug release; pellets

资金

  1. Fundacao para a Ciencia e Tecnologia, Portugal [SFR/BD/18330/2004]

向作者/读者索取更多资源

Background: Colon-specific delivery of drugs can be achieved with dosage forms coated with biopolymers that are metabolized selectively by the colonic microflora and yet resistant to enzymatic digestion in the small intestine. Aim: The aim of this study was to study the influence of formulation factors on the performance of mixed films from high-amylose starches and Surelease (R), applied using a spray-coating process, as potential colon-specific delivery devices. Methods: 5-Aminosalicylic acid-loaded pellets were prepared by an extrusion-spheronization process and film coated with mixtures of the starches and Surelease (R). Optimization of the coating formulation, that is, starch-to-Surelease (R) ratio, film-coating thickness, and type of starch, was undertaken first in enzyme-free media resembling the conditions in the stomach and small intestine. The effect of curing of the film coating on the drug release profile upon storage was also evaluated. Optimized coating formulations were further assessed for enzymatic digestibility using artificial gastric and intestinal juices containing commercially available pepsin and pancreatin or a-amylase from hog pancreas, respectively. Finally, drug release was assessed in fluid-simulating conditions in the colon (SCF) containing Bacillus licheniformis alpha-amylase. Results: Film coatings comprising high-amylose starches and Surelease (R) in a ratio of 1: 2 (w/w) and film thickness of approximately 45 mu m were able to withstand the chemical and enzymatic environment of the upper gastrointestinal tract, in particular, resisted degradation by the pancreatic alpha-amylases. Stability of the coatings during storage was achieved with additional curing. In SCF, these coatings were susceptible to enzymatic degradation. Conclusions: This study showed that high amylose starch-mixed films can be successfully used as colon-specific delivery devices. The preparation of the coating dispersions described is simple and rapid, without the need to extract the amylose component of starch.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Physical

Preclinical developments of natural-occurring halloysite clay nanotubes in cancer therapeutics

Irina Pereira, Mahdi Saleh, Claudia Nunes, Salette Reis, Francisco Veiga, Ana Claudia Paiva-Santos

Summary: Halloysite clay nanotubes (HNTs) are promising materials for anticancer nanotherapeutic strategies, used in various cancer research and treatments, although further research is needed to determine their toxicological risks and efficacy. They are envisioned as platforms for cancer multi-agent therapy.

ADVANCES IN COLLOID AND INTERFACE SCIENCE (2021)

Review Pharmacology & Pharmacy

Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination

Miguel Pereira-Silva, Gaurav Chauhan, Matthew D. Shin, Clare Hoskins, Marc J. Madou, Sergio O. Martinez-Chapa, Nicole F. Steinmetz, Francisco Veiga, Ana Claudia Paiva-Santos

Summary: Nano-based approaches, particularly cell membrane-based nanoparticles, have shown promise in enhancing antigen delivery, prolonging drug circulation, and improving drug delivery for COVID-19 treatment by blocking SARS-CoV-2 binding, reducing inflammation, and improving drug delivery.

EXPERT OPINION ON DRUG DELIVERY (2021)

Article Thermodynamics

Transport properties of aqueous solutions of the oncologic drug 5-fluorouracil: A fundamental complement to therapeutics

Luis M. P. Verissimo, Ines Cabral, Ana M. T. D. P. V. Cabral, Gianluca Utzeri, Francisco J. B. Veiga, Artur J. M. Valente, Ana C. F. Ribeiro

Summary: The paper discusses the transport properties of 5-fluorouracil and highlights the importance of precise dosing in cancer pharmacology. Experimental data is used to calculate descriptive parameters and provide further interpretation based on established models.

JOURNAL OF CHEMICAL THERMODYNAMICS (2021)

Review Pharmacology & Pharmacy

Development of nanostructured systems using natural polymers to optimize the treatment of inflammatory bowel diseases: A prospective study

Izabela B. C. Lima, Lina Clara. G. A. I. Moreno, Edson C. Silva-Filho, Juan M. Irache, Francisco J. B. Veiga, Hercilia M. L. Rolim, Livio C. C. Nunes

Summary: Inflammatory bowel disease is a chronic condition with symptoms such as diarrhea, abdominal pain, weight loss, rectal bleeding, and anemia. Nanosystems, particularly those utilizing chitosan as the main polymer, show potential in optimizing treatment by increasing drug absorption and reaching the inflamed colon effectively. Although studies in this area are still relatively new, they demonstrate promising therapeutic benefits.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2021)

Review Chemistry, Inorganic & Nuclear

Emerging role of nanoclays in cancer research, diagnosis, and therapy

Diana Peixoto, Irina Pereira, Miguel Pereira-Silva, Francisco Veiga, Michael R. Hamblin, Yuri Lvov, Mingxian Liu, Ana Claudia Paiva-Santos

Summary: Nanoclays with tunable properties, such as physicochemical, morphological, and structural, show potential as multifunctional biocompatible nanocarriers for versatile applications in cancer research, diagnosis, and therapy.

COORDINATION CHEMISTRY REVIEWS (2021)

Review Pharmacology & Pharmacy

Nanotechnology-based formulations toward the improved topical delivery of anti-acne active ingredients

Ana Claudia Paiva-Santos, Filipa Mascarenhas-Melo, Sara Cabanas Coimbra, Kiran D. Pawar, Diana Peixoto, Raquel Cha-Cha, Andre R. T. S. Araujo, Celia Cabral, Selmo Pinto, Francisco Veiga

Summary: Nanosystems offer advantages such as controlled release of active ingredients, improved skin permeation, and reduced skin irritation. However, new nanotechnological strategies may bring about new side effects and environmental nano pollution. More studies are needed to ensure the safety of consumers and the environment in the future.

EXPERT OPINION ON DRUG DELIVERY (2021)

Review Chemistry, Multidisciplinary

Ethosomes as Nanocarriers for the Development of Skin Delivery Formulations

Ana Claudia Paiva-Santos, Ana Luisa Silva, Catarina Guerra, Diana Peixoto, Miguel Pereira-Silva, Mahdi Zeinali, Filipa Mascarenhas-Melo, Ricardo Castro, Francisco Veiga

Summary: The use of nanotechnology in developing efficient drug delivery systems, such as ethosomes, which contain a high concentration of ethanol, has unique advantages in enhancing drug permeation across the skin. Ethosomes show promise as an alternative to traditional liposomes for delivering therapeutic agents for various skin pathologies, with potential applications in acne, psoriasis, alopecia, skin infections, hormonal deficiencies, among others. Further research is needed to fully explore the potential of ethosomal-based formulations in skin delivery of active ingredients.

PHARMACEUTICAL RESEARCH (2021)

Review Engineering, Biomedical

Nanomaterials in hair care and treatment

Miguel Pereira-Silva, Ana Margarida Martins, Ines Sousa-Oliveira, Helena Margarida Ribeiro, Francisco Veiga, Joana Marto, Ana Claudia Paiva-Santos

Summary: This review focuses on the breakthrough of nanomaterials in hair care and treatment, highlighting their potential as innovative multifunctional nanomaterials.

ACTA BIOMATERIALIA (2022)

Article Pharmacology & Pharmacy

Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach

Ana Santos, Catia Domingues, Ivana Jarak, Francisco Veiga, Ana Figueiras

Summary: Osteosarcoma (OS) is the most common primary malignant tumor of bone in children. Nanotechnology has developed exosomes as drug delivery systems that can release drugs directly at the tumor cells and reduce their toxicity.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)

Review Pharmacology & Pharmacy

A quality by design (QbD) approach in pharmaceutical development of lipid-based nanosystems: A systematic review

Daniela M. Zagalo, Branca M. A. Silva, Claudia Silva, Sergio Simoes, Joao Jose Sousa

Summary: There has been significant progress in utilizing Nanotechnology for novel drug delivery systems and targeted therapies, with a focus on lipid-based nanosystems. While lipid-based nanosystems show promise in improving drug safety, stability, and delivery efficiency, concerns over their quality, efficacy, and safety have arisen as they become more widely used.

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2022)

Review Chemistry, Multidisciplinary

Nanotechnology-based sunscreensda review

A. C. Santos, J. Marto, R. Cha-Cha, A. M. Martins, M. Pereira-Silva, H. M. Ribeiro, F. Veiga

Summary: Sun protection is essential for preventing the damaging effects of solar UV radiation, with sunscreen formulations incorporating nanosystems showing improved efficiency and safety. This review discusses the use of various nanosystems like nanoemulsions, liposomes, and solid lipid nanoparticles in sunscreens, as well as the potential impacts on human health and regulatory approaches worldwide.

MATERIALS TODAY CHEMISTRY (2022)

Review Pharmacology & Pharmacy

Application of nanotechnology in management and treatment of diabetic wounds

Filipa Mascarenhas-Melo, Maria Beatriz S. Goncalves, Diana Peixoto, Kiran D. Pawar, Victoria Bell, Vivek P. Chavda, Hajra Zafar, Faisal Raza, Ana Claudia Paiva-Santos, Ana Claudia Paiva-Santos

Summary: Diabetic wounds are a common health issue worldwide, and nanotechnology has emerged as a promising tool in their treatment. Nanosystems loaded with various active ingredients have shown improved properties and can effectively promote wound healing, angiogenesis, and synthesis of extracellular matrix compounds. Despite limitations, nanotechnology has gained significant attention and is considered valuable in the treatment and dressing of diabetic wounds.

JOURNAL OF DRUG TARGETING (2022)

Review Chemistry, Medicinal

Regulatory Science Approach in Pharmaceutical Development of Follow-on Versions of Non-Biological Complex Drug Products

Daniela M. Zagalo, Sergio Simoes, Joao Sousa

Summary: Scientific and technological breakthroughs in the field of Nanotechnology have played a significant role in the development and approval of Non-Biological Complex Drugs (NBCDs). However, the rapid expansion of NBCDs and their follow-on versions have posed various challenges in terms of science, technology, and regulation. The lack of official recognition and dedicated regulatory pathway for NBCDs, as well as the absence of clear and consistent guidance documents, have hindered the acceptance and potential of these drug products. The inconsistent regulatory approaches across different agencies and countries have also created uncertainty and may affect patient access to high-quality NBCD follow-on versions. Therefore, there is a need to establish a specific regulatory pathway or optimize existing pathways to address the complexity of NBCDs and their follow-on versions. This review aims to critically examine and provide an overview of the current regulatory landscape of NBCDs and follow-on versions, with the goal of filling regulatory and scientific gaps in establishing therapeutic equivalence.

JOURNAL OF PHARMACEUTICAL SCIENCES (2022)

Article Pharmacology & Pharmacy

Quality by design (QbD) approach in marketing authorization procedures of Non-Biological Complex Drugs: A critical evaluation

Daniela M. Zagalo, Joao Sousa, Sergio Simoes

Summary: The emergence of innovator-driven complex drug products, such as NBCDs, has led to advancements in nanotechnology and biotechnology fields. However, the design and development of NBCDs face challenges in scientific and regulatory assessment of pharmaceutical quality. Quality by Design (QbD) provides a holistic approach to address these challenges and ensure consistent high-quality pharmaceutical products. Regulatory authorities recommend QbD-based submissions for successful translation of NBCDs from research to the pharmaceutical market. This article aims to comprehensively investigate the implementation of QbD in NBCD development and marketing authorization in Europe and the United States.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)

Article Engineering, Chemical

Can Celecoxib Assay in Preclinical Studies Be Improved?

Maria Mendes, Joao Sousa, Alberto Pais, Carla Vitorino

Summary: A rapid, accurate, precise, and sensitive RP-HPLC method was developed for the quantification of celecoxib in five mouse matrices. The method met the acceptance criteria specified in FDA and EMA guidelines and was effectively applied for the quantification and biodistribution study of celecoxib in mice.

PROCESSES (2023)

暂无数据